Weight Loss Drug Competition, Weak Jobs Data, and Bitcoin's Drop: Bloomberg Money Minute
Bloomberg PodcastsFebruary 5, 20261 min125 views
2 connectionsΒ·4 entities in this videoβWeight Loss Drug Market Competition
- π Hims and Hers Health is entering the weight loss drug market with a lower-cost version of Novo Nordisk's WGOI pill.
- π° This generic version will be priced at $49 per month, significantly undercutting the brand-name drug.
- π Hims and Hers shares saw a slight increase, while Eli Lilly, maker of Zepbound, experienced a 7% drop.
Wall Street Reacts to Economic Data
- π Stock markets, including the Dow, Nasdaq, and S&P, are down approximately 3/4 of a percent.
- π» The sell-off is attributed to a continued decline in tech stocks, particularly software and chipmakers.
- β οΈ Concerns about the US labor market are also spooking investors.
US Labor Market Indicators
- π The JOLTS report indicated a fall in advertised job openings in December.
- π Jobless claims spiked higher last week.
- π Corporate layoffs more than doubled in January compared to the previous year.
Bitcoin's Price Decline
- π Bitcoin has fallen to what appears to be a year-and-a-half low.
- π° The cryptocurrency is currently valued at approximately $68,000.
Knowledge graph4 entities Β· 2 connections
How they connect
An interactive map of every person, idea, and reference from this conversation. Hover to trace connections, click to explore.
Hover Β· drag to explore
4 entities
Chapters1 moments
Key Moments
Transcript4 segments
Full Transcript
Topics14 themes
Whatβs Discussed
Weight Loss DrugsHims and Hers HealthNovo NordiskEli LillyZepboundWall StreetStock MarketTech StocksUS Labor MarketJOLTS ReportJobless ClaimsLayoffsBitcoinCryptocurrency
Smart Objects4 Β· 2 links
CompaniesΒ· 2
ProductsΒ· 2